RSV, flu and COVID-19
HealthPartners to research long-term effects of RSV vaccine during pregnancy
"The award is from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and it's for $3.4 million to study the prenatal RSV vaccine in relation to birth outcomes, lactation-related outcomes and child health outcomes up to age three," Palmsten explained.
Each year, up to 160,000 older adults in the United States are hospitalized due to respiratory syncytial virus, or RSV, and ...
This is the first RSV vaccine approved in Singapore for use in older adults and pregnant individuals, providing critical ...
RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for ...
This week, the Yukon-Kuskokwim Health Corporation will fly to almost two-dozen villages across the delta to deliver RSV ...
Results looking at the first season of RSV use shows that it is 75% effective at preventing RSV-associated hospitalizations ...
A vaccine against RSV is available for the first time. Researchers in Scotland have been reviewing the evidence to find out how effective it is ...
Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...
British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
The 2024-25 respiratory season is underway and for the first time, New Brunswick will offer some seniors immunization against ...
It could also help free up thousands GP appointments and hospital beds, researchers said. The review by experts at the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback